...
首页> 外文期刊>Polyhedron: The International Journal for Inorganic and Organometallic Chemistry >Novel morpholine liganded Pd-based N-heterocyclic carbene complexes: Synthesis, characterization, crystal structure, antidiabetic and anticholinergic properties
【24h】

Novel morpholine liganded Pd-based N-heterocyclic carbene complexes: Synthesis, characterization, crystal structure, antidiabetic and anticholinergic properties

机译:新型吗啉配合PD基N-杂环碳化物络合物:合成,表征,晶体结构,抗糖尿病和抗胆碱能性质

获取原文
获取原文并翻译 | 示例
           

摘要

This study involves the synthesis of novel N-heterocyclic carbene (NHC)PdX2(morpholine) complexes (1a-i). These Pd-based complexes are synthesized from pyridine enhanced precatalyst preparation stabilization and initiation (PEPPSI) complexes and morpholine. The new complexes were characterized by spectroscopy (IR, H-1 and C-13 NMR) techniques. Also, the crystal structures of lb and if were obtained by utilizing the single-crystal X-ray diffraction method. The synthesized compounds in this study were investigated for their inhibition action against equin serum butyrylcholinesterase (BChE) and Electrophorus electricus acetylcholinesterase (AChE) as the capability drug aims for Alzheimer's disease (AD). These novel morpholine liganded Pd-based N-heterocyclic complexes were good inhibitors of BChE, alpha-glycosidase, cytosolic carbonic anhydrase I and II isoforms (hCA I and II), and AChE, with K-i values in the range of 10.77 +/- 1.01-45.86 +/- 5.65 mu M for hCA I, 25.42 +/- 5.18-57.82 +/- 3.01 mu M for hCA II, 12.26 +/- 3.32-50.36 +/- 6.19 mu M for a-glycosidase, 9.97 +/- 1.26-60.75 +/- 15.98 M for BChE, and 10.28 1.55-30.12 3.22 M for AChE. The inhibition of the alpha-glycosidase enzyme, an important carbohydrate hydrolyzing catalyst, could be used as one of the efficient methodologies in both treating and preventing diabetes by controlling the suppressing postprandial hyperglycemia and postprandial glucose amounts. (C) 2018 Elsevier Ltd. All rights reserved.
机译:该研究涉及新型N-杂环基(NHC)PDX2(Mupholine)复合物(1A-I)的合成。这些Pd基配合物由吡啶增强的预催化剂制剂稳定和引发(百ppsi)配合物和吗啉合成。通过光谱学(IR,H-1和C-13 NMR)技术表征新的复合物。而且,通过利用单晶X射线衍射方法来获得LB的晶体结构。研究了该研究中的合成化合物,用于将其抑制作用血清丁酰胆碱酯酶(BCHE)和电泳乙酰胆碱酯酶(ACHE)的抑制作用,因为该能力药物针对阿尔茨海默病(AD)。这些新的吗啉配合Pd基N-杂环复合物是BCHE,α-糖苷酶,细胞源酶,胞质碳酸酐酶I和II同种型(HCA I和II)的良好抑制剂,并且疼痛,Ki值在10.77 +/- 1.01的范围内-45.86 +/- 5.65微米为HCA I,25.42 +/- +/- 5.18-57.82 3.01微米为HCA II,12.26 +/- +/- 3.32-50.36 6.19微米为糖苷酶,9.97 + / - BCHE的1.26-60.75 +/- 15.98米,疼痛的3.22米为1.55-30.12。 α-糖苷酶是一种重要的碳水化合物水解催化剂,可作为治疗和预防糖尿病的有效方法之一,通过控制抑制的餐后高血糖和餐后葡萄糖量。 (c)2018年elestvier有限公司保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号